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This paper attempts to clarify the nature of chemical sensitivity by proposing a theory of disease
that unites the disparate clinical observations associated with the condition. Sensitivity to
chemicals appears to be the consequence of a two-step process: loss of tolerance in susceptible
persons following exposure to various toxicants, and subsequent triggering of symptoms by
extremely small quantities of previously tolerated chemicals, drugs, foods, and food and drug
combinations including caffeine and alcohol. Although chemical sensitivity may be the
consequence of this process, a term that may more clearly describe the observed process is
toxicant-induced loss of tolerance. Features of this yet-to-be-proven mechanism or theory of
disease that affect the design of human exposure studies include the stimulatory and
withdrawallike nature (resembling addiction) of symptoms reported by patients and masking.
Masking, which may blunt or eliminate responses to chemical challenges, appears to have
several components: apposition, which is the overlapping of the effects of closely timed
exposures, acclimatization or habituation, and addiction. A number of human challenge studies in
this area have concluded that there is no physiological basis for chemical sensitivity. However,
these studies have failed to address the role of masking. To ensure reliable and reproducible
responses to challenges, future studies in which subjects are evaluated in an environmental
medical unit, a hospital-based facility in which background chemical exposures are reduced to the
lowest levels practicable, may be necessary. A set of postulates is offered to determine whether
there is a causal relationship between low-level chemical exposures and symptoms using an
environmental medical unit. Environ Health Perspect 105(Suppl 2):445-453 (1997)
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sensitivity, sensitization, tolerance, addiction, habituation
Introduction
Clinical observations in North America
(1-7) and Europe (8) point to an expand-
ing group ofpatients who report sensitivities
to extraordinarily low levels ofenvironmen-
tal chemicals. This phenomenon, termed
chemical sensitivity or multiple chemical
sensitivity, appears to develop de novo in
some individuals following acute or chronic
exposure to a wide variety ofenvironmental
agents including various pesticides, solvents,
drugs, and air contaminants in so-called sick
buildings. Some practitioners have attributed
a broad spectrum ofchronic medical condi-
tions involving any and every organ system
to chemical sensitivity (Figure 1) (4).
Efforts to formulate a case definition for
chemical sensitivity, to identify relevant
biomarkers, and to explore a variety of
mechanisms for the condition have esca-
lated over the past decade. Several conflict-
ing schools of thought have evolved with
respect to underlying mechanisms, ranging
from the purely psychological to the wholly
physiological. In the midst of the tumult
surrounding chemical sensitivity lies a pro-
found but little-recognized scientific debate
concerning the origins of disease. Some
participants in this debate are challenging
currently accepted notions concerning the
causes for many chronic illnesses.
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This paper attempts to clarify the nature
ofchemical sensitivity by describing a gen-
eral mechanism that appears to underlie
these cases; proposes a theory of disease
based upon this general mechanism; and
offers a set oftestable postulates for corrobo-
rating or refuting this theory. Science is not
about opinion or belief; it is about "guess
and test," that is, formulating hypotheses
and then devising experiments to test them.
Terminology
Phenomenologically, chemical sensitivity
appears to develop in two stages (3,4).
First is the loss of tolerance (possibly but
not necessarily due to sensitization) follow-
ing acute or chronic exposure to various
environmental agents such as pesticides,
solvents, or contaminated air in a sick
building. Second is the subsequent trigger-
ing ofsymptoms by extremely small quan-
tities of previously tolerated chemicals,
drugs, foods, and food and drug combina-
tions (Figure 2). Although sensitivity to
chemicals may be one of the consequences
ofthis two-stage process, the term chemical
sensitivity does not appropriately describe
the process involved.
There are two principal reasons for this.
First, although chemical sensitivity cer-
tainly sounds like an inconvenient problem
to have, the words fail to convey the poten-
tially disabling nature ofthe condition and
its postulated origins in a toxic exposure.
Some researchers balk at using the word
toxic in this manner. However, numerous
investigators from different geographic
regions have published strikingly similar
descriptions ofindividuals who report dis-
abling illnesses after exposure to recognized
environmental contaminants, albeit at levels
not generally regarded as toxic (1,9-12).
Yet, for these individuals, the exposure
appears to have been toxic.
Paracelsus aptly opined that dose makes
the poison. However, as our knowledge has
grown, it has become evident that dose +
host makes the poison (for example, pack-
years ofsmoking plus a-l-antitrypsin defi-
ciency). Similarly, in the case of chemical
sensitivity, not everyone exposed in a sick
building or to a chemical spill develops
chronic illness. Thus, it may be concluded
that individual susceptibility, whether
physiological or psychological, must play a
role in determining who gets sick. The term
chemical sensitivity fails to convey this key
observation that chemical exposures appear
to initiate a process that results in chemical
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Ear, nose, and throat
*Sinusitis
* Polyps
*Tinnitus
*Recurrent otitis
Miscellaneous
* Chronic fatigue syndrome
* Implant syndromes
* GulfWarsyndrome
Skin
Neuropsychological
* Multiple chemical sensitivity
* Attention deficit hyperactivity
disorder (ADHD)
* Depression/manic depression
* Migraines and other headaches
* Seizures
* Eczema
*Hives
* Other rashes, eruptions
Cardiovascular
*Arrhythmias
* Hypertension
* Hypotension
* Raynaud's phenomenon
Respiratory
*Asthma
* Reactive airways dysfunction
syndrome(RADS)
*Toluene diisocyanate ITDI)
hypersensitivity
Gastrointestinal
* Irritable bowel
*Reflux
Connective tissue/musculoskeletal
* Fibromyalgia
* Carpal tunnel syndrome
*Temporomandibular joint (TMJ) dysfunction syndrome
*Arthritis
*Lupus
Figure 1. Some conditions that have been attributed to chemical sensitivity.
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Figure 2. Phenomenology of chemical sensitivity.
Chemical sensitivity appears to develop in two stages:
Stage 1-loss of specific tolerance following acute or
chronic exposure to various environmental agents such
as pesticides, solvents, or contaminated air in a sick
building; and Stage 2-subsequent triggering of symp-
toms by extremely small quantities of previously toler-
ated chemicals, drugs, foods, and food and drug
combinations (e.g., traffic exhaust, fragrances, caffeine,
alcohol). Physicians formulate a diagnosis based on
symptoms reported tothem bytheir patients. Because of
masking, both physicians and patients may fail to
observe thateveryday low-level exposures aretriggering
symptoms. Sometimes even when such triggers are rec-
ognized, an initial exposure event that initiated loss of
specific tolerance maygo unnoticed ormay notbe linked
bythe physician orthe patienttothe patient's illness.
sensitivity. Conceivably, this phenomenon
could represent a new type oftoxicity.
The second problem with the term
chemical sensitivity is that it suggests that
those afflicted become intolerant ofchemi-
cal exposures only when, in fact, caffeine,
alcoholic beverages, various drugs, and
foods reportedly trigger symptoms in these
individuals once the process has been initi-
ated (4,12-15). For the above reasons,
chemical sensitivity is a misnomer for the
process under discussion. An alternative
term, toxicant-induced loss of tolerance
(TILT), has been proposed (16). This term
offers several advantages. First, it describes
the process as it has been observed by clini-
cians and patients. Second, it allows for the
possibility that various toxicants may initi-
ate the process. Third, it does not limit the
resulting intolerance to chemicals. Finally,
it sharpens the focus ofthe current debate
over chemical sensitivity by positing a
theory ofdisease that can be subjected to
objective testing.
Historically, new theories of disease
arose when physicians observed patterns of
illness that did not fit accepted explanations
for disease at that time, for example, the
germ theory or the immune theory ofdis-
ease. Similarly, many ofthe illnesses under
discussion here do not conform to current
accepted explanations for disease or toxicity.
Objections to the concept ofchemical sen-
sitivity have included concerns that: too
many different chemicals have been said to
cause chemical sensitivity; patients report
too many symptoms involving any and
every organ system; no known physiological
mechanism explains chemical sensitivity; no
biomarker has been identified for chemical
sensitivity; and total avoidance ofchemicals
is impractical.
Theories ofdisease attempt to explain
what is going on inside the patient (a
"black box") before overt illness, as illus-
trated below:
Agent Hs Big response
A theory ofdisease is ayet-to-be-established,
general mechanism for a class or family of
diseases. For the germ theory ofdisease, the
boxes depicting the general mechanism of
infection wouldlooksomething like this:
Germ Host 1 _Big response
Germs
reproduce
Later
Germ - Host 2 Big response
Germs
reproduce
Note that: many different kinds of
germs cause responses; there are many dif-
ferent responses involving any and every
organ system (skin, respiratory, gastroin-
testinal); specific mechanisms vary gready-
for example, cholera versus AIDS versus
shingles; there is no single biomarker-
identification ofspecific germs took years;
and prevention (avoidance, antiseptics, san-
itation, use ofgloves) preceded knowledge
ofspecific mechanisms.
For the immune theory ofdisease, the
boxes might looklike this:
Antigen-| Host 1
Antibodies
Later
Antigen _ - Host 1 r Big response
-t\ \, A)
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Here, just as for the germ theory of
disease: many different kinds of antigens
cause responses; there are many different
responses involving any and every organ
system (skin, respiratory, gastrointestinal);
specific mechanisms vary greatly-for
example, poison ivy versus allergic rhinitis
versus serum sickness; there is no single
biomarker-identification ofspecific anti-
bodies took years; and prevention (avoid-
ance, allergy shots) preceded knowledge of
specific mechanisms.
For toxicant-induced loss of tolerance,
the boxes might look like this:
Chemical -_ Host 1
Loss of
tolerance
Later
chemicals - [ 3 _ Big response
For toxicant-induced loss of tolerance, as
for the germ and immune theories ofdis-
ease: many different kinds of chemicals
may cause responses; there may be many
different responses involving any and every
organ system; specific mechanisms may
vary greatly; it is conceivable that there is
no single biomarker for response-identifi-
cation ofbiomarkers may take years; and
prevention (avoidance of initiators or trig-
gers) may precede knowledge ofspecific
mechanisms.
Although the concept loss oftolerance
may sound vague, in fact it is not. What
these individuals report is a loss ofspecific
tolerance to particular chemicals, foods,
and drugs. (16). Note that this theory does
not exclude the possibility that toxicant-
induced loss oftolerance could turn out to
be a special kind oftoxicity or a variation
on the immune theory of disease just as
allergy and delayed-type hypersensitivity
are special cases that fall under the general
classification ofimmunologic disorders. A
consequence ofviewing TILT as a theory
of disease would be a shift in perspective
from chemical sensitivity as a syndrome to
chemical sensitivity, now TILT, as a class
ofdisorders parallel to infectious diseases
or immunologic diseases. Much effort has
been devoted to developing a case defini-
tion for chemical sensitivity, with a singular
lack ofsuccess. This lack ofsuccess would
not be surprising if in fact TILT repre-
sented a new class or family ofdisorders.
Certainly, it would not be feasible to
develop a single clinical case definition
that would embrace all infectious or all
immunologic diseases.
Theories of disease that withstand
scientific scrutiny arise infrequently. The
past century has witnessed the inculcation
of the germ and immune theories ofdis-
ease into medical practice. Equating toxi-
cant-induced loss oftolerance to either one
ofthese theories, both ofwhich have been
widely corroborated, would be premature
and presumptuous. On the other hand,
toxicant-induced loss oftolerance has cer-
tain earmarks ofan emerging theory ofdis-
ease, including the vituperative professional
disputes that surround it (16).
Features ofTILT Relevant
for Its Testing
As described by many investigators, this
phenomenon appears to involve a two-
stage process. Because ofethical considera-
tions, the first stage (initiation) is more
difficult to model in humans than the sec-
ond stage (triggering). Ultimately, epi-
demiologic studies and animal models may
elucidate the first stage. Fortunately, the
second stage readily lends itself to testing
via direct human challenges, a potent form
of scientific evidence. However, in the
design ofhuman challenge studies in this
area, certain key clinical observations must
be taken into account. First, the commonly
reported biphasic, stimulatory-and-with-
drawallike pattern ofthe patients' symp-
toms, particularly those symptoms involving
the central nervous system, must be under-
stood to perform meaningful test challenges
on these patients. Second, a related phe-
nomenon called masking (to be described
further) may hide responses to low-level
chemical challenges and therefore may need
to be minimized before testing. Controlling
masking may be analogous to controlling
background noise in studies on sound.
The following sections will discuss
these clinical features, their incorporation
in experimental designs, and how failure to
do so might threaten research outcomes.
Stimulatoryand
WithdrawalSymptoms
Randolph first described the time course of
the responses ofthese individuals to chemi-
cals and foods (17). He reported striking
parallels between their symptoms and those
associated with alcohol and drug addiction.
Randolph viewed the food and caffeine
addictions his patients exhibited as the
bottom rungs in a hierarchy ofaddiction,
proceeding from foods and food and drug
combinations such as caffeine and alcohol
on the lower rungs upward to nicotine and
other naturally occurring and synthetically
derived drugs (14).
Chemically sensitive patients resemble
drug addicts in that members of both
groups often report intense cravings and
debilitating withdrawal symptoms. How-
ever, chemically sensitive patients' responses
are not primarily to drugs. These individu-
als more commonly report addictions to
caffeine or certain foods. While drug
addicts manifest ad-dicted behaviors (Latin
ad "toward" + dicare "proclaim"), chemi-
cally sensitive patients respond as though
they were ab-dicted (Latin ab "away from"
+ dicare "proclaim") and assiduously avoid
the very substances addicted persons favor
including alcohol, drugs and nicotine.
The stimulatory and withdrawal symp-
toms reported by chemically sensitive
patients are frequently identical to those
reported by normal persons exposed to
much greater amounts of the same sub-
stances. For example, after drinking one
cup ofcoffee, chemically sensitive patients
may report feeling hyperactive, jittery, talk-
ative, nervous, anxious, or experiencing
paniclike symptoms (stimulatory phase).
Hours to days later, they may report with-
drawal symptoms such as fatigue, yawning,
confusion, indecisiveness, irritability,
depression, loss of motivation, blurred
vision, headaches, flulike symptoms, hot or
cold spells, or heaviness in their arms and
legs (withdrawal phase). Similar symptoms
occur during caffeine withdrawal among
some low-to-moderate caffeine users in the
general population (18). Large numbers of
chemically sensitive patients and many
GulfWar veterans with unexplained ill-
nesses report that one drink ofan alcoholic
beverage causes inebriation and/or a severe
hangover (12,15,19). These augmented
responses suggest that those afflicted have
lost their previous natural or native tolerance
for such exposures.
Early in their illnesses, before elimi-
nating caffeine from their diets, many
chemically sensitive patients report having
consumed chocolate, coffee, tea, or cola
addictively, often in very large quantities
(15). Some carried large containers ofcof-
fee or tea around wherever they went.
Many report later stopping use of all caf-
feine and xanthines, generally on the
advice ofa friend or physician, and subse-
quently experiencing several days ofintense
withdrawal symptoms. Frequently they
report that it was only after eliminating all
xanthines from their diets that they were
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able to discern the effects ofconsuming a
single cup ofcoffee or a chocolate bar. Most
report becoming aware of the unpleasant
effects ofcaffeine only after a trial ofpartial
or complete caffeine avoidance. In this
regard, chemically sensitive patients resem-
ble certain reformed smokers or alcoholics
who after quitting their addictants report
extreme sensitivity to minute amounts of
the addicting agents. Terms like addiction,
withdrawal, and detox pepper the vocabu-
lary ofchemically sensitive patients. One
patient described the condition as being
"like drug abuse without any ofthe fun."
These parallels to addiction provide per-
spective: they may help explain why the
mechanisms that underlie chemical sensi-
tivity have been difficult to define and why
biological markers have proven elusive.
In summary, drug addiction and TILT
share a number of features in common.
TILT also has features reminiscent oftoxi-
city and allergy (Table 1). However, it is its
resemblance to addiction that is perhaps
most striking and that has escaped the atten-
tion ofmanyphysicians and researchers.
Masking
Suppose that TILT was a mechanism
underlying certain cases ofchronic fatigue,
migraine, asthma, or depression. It might
be reasonable to wonder, then, whypatients
experiencing these symptoms do not also
report chemical intolerances. In fact, some
but not all patients do report them (21,22).
Many chemically sensitive patients with
these same diagnoses report that it was not
until they accidentally or intentionally
avoided a sufficient number oftheir prob-
lem incitants that they noticed feeling bet-
ter. Then, when they reencountered one of
those incitants, robust symptoms occurred.
As they repeated this iterative process of
avoidance and reexposure, they noticed
that particular symptoms occurred with
particular exposures. Most indicate that
had they not avoided many chemicals and
foods simultaneously, or unmasked them-
selves, they might not have determined
what was making them sick.
Masking and unmasking are colorful lay
terms for which there is no scientific equiv-
alent. Nevertheless, investigators' abilities to
understand masking and unmasking and
manipulate these variables knowledgeably
may determine the success ofstudies in this
area. When chemically sensitive patients
follow a diet free oftheir problem foods
and live in a relatively chemical-free home
in the hills of central Texas where there
are no major agricultural or industrial
Table 1. Features oftoxicant-induced loss oftolerance compared with features of addiction, allergy, and toxicity.
Toxicant-induced
Feature loss oftolerancea Addictiona Allergya Toxicitya
Chemical/drug intolerance + + + +
Ambient air incitants + + +
Food intolerance + +
Alcohol intolerance + +
Caffeine intolerance + +
Withdrawal symptoms + +
Craving, binging + (foods) +(drugs)
Sensitization + +
Induction by chemicals + +b +
Induction by biologicals +
Multisystem symptoms + + + +
Frequent CNS symptomatology + + +
Well-defined mechanism(s) + +
Genetic susceptibility + + + +
Dose-response relationship +C +C +
"Categories are not pure and may overlap in a given host, e.g., haptenation of a chemical toxin may initiate an
immunologic response; brain and liver toxicity may accompany alcohol addiction. bLow molecular weight chemi-
cals may combine with tissue proteins producing haptens that evoke immune responses. cDose response does
occur for allergens. With the first sensitizing exposure in a susceptible individual, there is a dose-response rela-
tionship; with subsequent exposures, the sensitized person also responds in proportion to dose but at a much
lower dose level (20). The same kind of dose-response relationship may hold true for TILT but this has not been
tested. Chemically sensitive individuals generally report increasingly severe symptoms the longer they remain in
exposure situations, an observation that suggests a dose-response relationship.
operations or air contaminants, they say
they are in an unmasked state. Under these
circumstances they claim that if a diesel
truck drove by they could identify specific
symptoms due to the diesel exhaust, for
example, irritability, headache, or nausea.
On the other hand, the patients report
that when they travel to a large city like
Houston or New York City, stay in a hotel
room, and eat in restaurants, they become
masked. In the presence of many concur-
rent exposures (exhaust, fragrances, volatiles
offgassing from building interiors, various
foods) in New York City many report feel-
ing chronically ill, as if they had flu. If a
diesel truck drove by under these circum-
stances, most report they would not be able
to attribute any particular symptoms to the
exhaust because ofbackground noise from
overlapping symptoms occurring as a con-
sequence ofoverlapping or successive expo-
sures. In theory, such background noise or
masking hides the effects of individual
exposures-responses are blurred.
Masking appears to involve at least three
interrelated components, any ofwhich may
interfere with the outcome of low-level
chemical challenges in these individuals:
acclimatization, apposition, and addiction.
In real life, these three components proba-
bly operate concurrently, although here
they are considered individually.
There is some notation that can be used
to help depict these components. In the
addiction literature, responses to addictive
Increasing
symptom
intensity
+ +
+
0-
Exposure
Time -
Figure 3. Graphic representation of symptom progres-
sion following exposure to a single substance in a per-
son sensitive to that substance (e.g., caffeine, a
solvent, alcohol, nicotine). The portion of the biphasic
curve above the line represents symptoms with onset
of exposure (stimulatory symptoms) and the portion of
the curve belowthe line represents symptoms with off-
set of exposure (withdrawal symptoms). Amplitude is
proportional to symptom severity. The length of the
curve (duration of symptoms) may range from minutes
to days.
drugs are often illustrated graphically using
a biphasic curve or sine wave (Figure 3).
The portion of the sine wave above the
horizontal axis represents symptoms with
onset ofexposure, often called stimulatory
symptoms; the portion below the horizon-
tal axis represents symptoms with offset or
cessation ofexposure, often referred to as
withdrawal symptoms. The height or
amplitude ofthe sine wave in either direc-
tion is proportional to the severity of the
response. For persons not sensitive to a
particular substance, the curve would be a
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flat line with zero amplitude in either
direction. The length ofthe biphasic curve
represents the duration ofsymptoms fol-
lowing an exposure, reportedly ranging
from minutes up to several days depending
upon the exposure and the individual. Of
course, the particular nature ofthe symp-
toms vary from one sensitive subject to the
next and from substance to substance.
Suppose researchers wished to test a
putatively sensitive subject by exposing him
to a low concentration ofxylene. Xylene is
a common indoor air contaminant and a
component ofMolhave's mixture (23) that
has been used in human inhalation chal-
lenge studies. How would the researchers
ensure that their subject was unmasked (at
true baseline) before challenge? The follow-
ing components ofmasking would need to
be considered andcontrolled:
Acclimatization. For most of the
population, with continuous or repeated
exposure to many environmental stressors,
adaptation occurs. That is, symptoms
diminish as exposure continues. Chemically
sensitive patients' symptoms also decrease
with continuing exposure; however, when
exposure ceases, these individuals often
report marked withdrawal symptoms.
Thus, what they describe is more akin to
habituation than to adaptation. Suppose
further that the subject who is challenged
with xylene works in a sick building where
he is routinely exposed to low levels of
xylene on a regular basis. Administering a
test exposure ofxylene below the odor
threshold (0.62 ppm) (24) may produce
little or no effect on the subject ifhe has
been working in that same building during
the preceding week (Figure 4). On the
other hand, ifhe avoided the building and
all other sources ofxylene for 4 to 7 days
before testing, a more robust response to
thexylene challenge might be anticipated.
Thus, a sensitive subject's response to a
challenge may range widely in intensity,
from none to maximal, depending on how
recently that person has been exposed to
the test substance or a chemically related
substance. Ifinsufficient time has elapsed,
for example, less than 4 days, the challenge
may yield a false negative response as a
result ofhabituation. Iftoo much time has
elapsed, for example, weeks or months,
sensitivity mayhavewaned.
Apposition. Suppose next that the
research subject is sensitive to multiple
substances. On the day he is scheduled for
challenge testing, he gets up in the morn-
ing, uses some scented soap or hair spray,
cooks breakfast on a gas stove, and drives
his car through heavy traffic to reach the
laboratory. Inside the laboratory building
he rides an elevator where he is exposed to
people wearing various colognes. Ifhe were
sensitive to several ofthese exposures, his
responses might overlap in time. Such
responses reportedly can last for hours or
days. Ifthis is true, they could persist dur-
ing a placebo challenge, resulting in a false
positive response. Thus, apposition or jux-
taposition of the effects of closely timed
exposures is a second component ofmask-
ing that must be controlled prior to and
during challenge studies (Figure 5).
Addiction. Many of the symptoms
reported by chemically sensitive patients
mirror those commonly associated with
addi,ction. Addiction may be a component
of masking. Addicted individuals con-
sciously or subconsciously time their next
"hit" so as to forestall withdrawal symp-
toms (Figure 6), a phenomenon that occurs
in alcohol, tobacco, and caffeine addic-
tions. However, addiction to foods also is
reported among chemically sensitive
patients. Randolph described wheat, eggs,
milk, and corn as the most common addic-
tants in his patients (14,17). Frequently
Exposure t t t t
Time -.
Figure 4. Graphic representation of acclimatization. Symptom severity decreases with repeated closelytimed expo-
sures (inhalant or ingestant) to the same substance. Acclimatization is not equivalentto adaptation, since patients
reportwithdrawal symptoms after exposures cease; conceptually, acclimatization more closely resembles habitua-
tion in this case.
Exposure
Time -* t t
Figure 5. Graphic representation of apposition. If an individual is sensitive to many different substances, the
effects of everyday exposures to chemicals, foods, or drugs may overlap in time. This apposition of effects might
lead to an individual who feels ill most of the time; however, neither the individual nor his physician notices the
effect of any single exposure. Apposition tends to mask the effect of interest (solid lines) in much the same way
that background noise masks a sound of interest.
Exposure t
Time -*
Figure 6. Graphic representation of addiction. A sensitive person who is addicted to caffeine, alcohol, nicotine, or
another substance maydeliberatelytake that substance atfrequent, carefullyspaced intervals to avoid unpleasant
withdrawal symptoms. Such exposures may also maskthe effect of interest (e.g., a challenge test using xylene).
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these individuals report intense cravings
and consume astounding quantities of
foods, for example, a pound ofchocolate,
several bags ofpopcorn, a dozen dough-
nuts, or 30 cups of coffee in one day.
Patients most often report this kind of
addictive consumption in the early stages of
their illness, before they practiced avoiding
problem exposures.
Foods may contain bioactive con-
stituents such as tyramine, monosodium
glutamate, and opiates (13). Persons who
routinely use tobacco, caffeine, alcohol, or
foods containing bioactive substances may
need to avoid these substances before test-
ing because the pharmacologic effects of
these agents could override or mask the
effect ofan experimental challenge. Failure
to eliminate addictants before testing could
result either in false positive challenges due
to lingering symptoms from an addictant
used in the hours or days preceding a
placebo challenge or in false negative
challenges due to masking by an addictant.
Testing the TILTTheory
After the germ theory ofdisease was intro-
duced in the late 1800s, manyoverly enthu-
siastic investigators who were careless in
their bacteriological techniques announced
they had discovered causative agents for
tuberculosis, yellow fever, and other dis-
eases. These pronouncements and subse-
quent retractions became so frequent that
in 1884 the President of the New York
Academy of Medicine lamented that a
bacteriomania had swept over the medical
profession (25). To prevent future such
pseudodiscoveries, Robert Koch, who iden-
tified the organisms responsible for tuber-
culosis, anthrax, and cholera, proposed a
set ofrules for etiological verification. His
postulates required that: the microbe must
present in every case ofthe disease; it must
be isolatable in pure culture; inoculating a
healthy animal with the culture must
reproduce the disease; and the microbe
must be recoverable from the inoculated
animal and be able to be grown again.
Just as bacteriomania engulfed the med-
ical profession in the 1880s, chemomania is
poised to engulf it now. Chemical sensitiv-
ity is in need ofa set ofpostulates to ensure
that future causal determinations are scien-
tifically based. Below is a set ofpostulates
that, ifmet, would confirm (and ifnot met,
refute) that a person's symptoms were
caused by a particular substance:
When a subject simultaneously avoids all
chemical, food and drug incitants, remis-
sion ofsymptoms occurs (unmasking).
Enter
EMU
t t . 4to 7 days - t- 4to 7 days *t
Figure 7. Graphic representation depicting the testing of the toxicant-induced loss of tolerance postulates using
an environmental medical unit. In the left-hand portion of the figure, a chemically sensitive individual is experienc-
ing symptoms in response to multiple exposures (chemicals, foods, drugs) before entering the environmental med-
ical unit. Effects overlap in time. The effect of any particular exposure cannot be distinguished from the effects of
other exposures, and the person's symptoms may appearto wax and wane unpredictably overtime. Postulate 1-
When all chemical, food,and drug incitants are avoided concurrently, remission of symptoms occurs. Anecdotally,
patients report going through withdrawal or detox for the first several days during which they experience symp-
toms such as increased irritability, headaches, and depression. After 4 to 7 days, most report feeling well and
theoretically are at a clean baseline. Postulate 2-A specific constellation of symptoms occurs with reintroduction
of an incitant. Postulate 3-Symptoms resolve when the incitant is again avoided. Postulate 4-Reexposure to
the same incitant within an appropriate window of time (estimated to be about 4-7 days) produces the same
symptoms. For research purposes, challenges should be conducted in a double-blind, placebo-controlled manner.
* A specific constellation of symptoms
occurs with reintroduction of a
particular incitant.
* Symptoms resolve when the incitant is
again avoided.
* With reexposure to the same incitant, the
same constellation of symptoms reoc-
curs, provided that the challenge is con-
ducted within an appropriate window
of time. Clinical observations suggest
that an ideal window is 4 to 7 days after
the last exposure to the test incitant.
To apply these postulates (illustrated in
Figure 7), the timing ofexposures and the
degree of masking should be rigorously
controlled. To accomplish this, a hospital-
based clinical research facility, an EMU, is
needed to isolate subjects from background
exposures (Figure 8) (4,5,15,16,26). The
EMU would be constructed, furnished,
and operated to minimize exposure to air-
borne chemicals. For example, no disinfec-
tants, perfumes, or pesticides would be
allowed in the unit. Ventilation would
maximize fresh outside air and provide
optimal particulate and gas filtration.
Patients would eat chemically less-contami-
nated foods and water, testing one food per
meal to determine the effects ofspecific
foods. Ifsymptoms persisted despite this
Figure 8. Preliminary design sketch of a patient room in an environmental medical unit. Note use of the nonout-
gassing construction materials and furnishings and point source control (ventilated television enclosure).
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approach, fasting for a few days would be
attempted before reintroducing single foods.
The rationale for housing subjects in an
environmentally controlled facility for sev-
eral days before challenges is 2-fold: to pre-
vent extraneous exposure of patients to
inhalants or ingestants so responses to them
are not misinterpreted as positive responses
when placebo challenges are administered
(false positives), and to minimize masking
that might blunt or eliminate responses to
active challenges (false negatives).
Although the terms exposure chamber
and environmental medical unit appear
similar, conceptually they differ in impor-
tant ways with regard to patient safety and
control ofinterfering exposures.
By definition, an EMU is in a hospital
where patients can remain 24 hr a day in a
dean environment for up to several weeks.
Like an intensive care unit or coronary care
unit, the EMU would be a specialized, ded-
icated hospital facility. The EMU must be
in a hospital to accommodate very sick
patients; exposure chambers do not offer
comparable levels ofcare. Because chemical
challenges may precipitate bronchoconstric-
tion, mental confusion, severe headaches,
depression, and other disabling symptoms,
these patients should not be tested in an
exposure chamber on an outpatient basis.
Conventional exposure chambers do
not reduce background chemical exposures
for extended periods (up to several weeks)
so the effects ofa particular challenge in a
patient can be assessed accurately. This is
the central limitation ofexposure chambers
and the reason they should not be used to
rule in or rule out chemical sensitivity. If
subjects are not kept in a clean environ-
ment for several days before and during
challenges, false positive responses may
occur because ofinterfering exposures and
false negative responses may occur because
of masking. In contrast to an exposure
chamber, an EMU would minimize inter-
fering exposures before and during chal-
lenges, thus maximizing the reliability and
reproducibility oftest responses.
Availability of an EMU would allow
physicians to refer awide variety ofcases in
which environmental sensitivities were sus-
pected to the unit for definitive evaluation.
There physicians could observe first-hand
whether a patient's symptoms improved
after several days on a special diet in a clean
environment. If improvement occurred,
single chemicals at concentrations encoun-
tered in normal daily living as well as single
foods could be reintroduced one at a time
while the effects ofeach introduction were
observed. Thus, the EMU would be a tool
to determine in the most direct and defini-
tive manner possible whether chemical sen-
sitivities exist. Studying patients with
complicated conditions like chronic fatigue
syndrome or GulfWar syndrome in a con-
ventional exposure chamber would not
provide the same information, since cham-
bers allow only short-term residence, do
not control the entire range ofbackground
contaminants, and provide inadequate sep-
aration from background exposures prior
to challenges.
An analogy may help illustrate the
importance of controlling exposures for
extended periods before challenge. If one
wished to determine whether a coffee
drinker's headaches were due to caffeine, it
would not be adequate simply to give the
person a cup ofcoffee and ask him how he
felt. It is obvious that the individual would
have to stop using caffeine for a period
before a meaningful test ofcaffeine sensi-
tivity could be performed. In this instance,
a false negative challenge likely would be
the result offailure to avoid coffee before
challenge. Similarly, placing a putatively
sensitive person in a conventional exposure
chamber and exposing him to a low con-
centration of a chemical might not pro-
duce any noticeable effect. On the other
hand, if this same person remained in a
clean environment such as an EMU for a
few days before being tested and his condi-
tion improved, one could then perform
meaningful challenges.
Placing patients in an EMU would
simultaneously control all three components
of masking: stopping all exposures several
days before challenge testing and spacing
test exposures 4 to 7 days apart would pre-
clude acclimatization or habituation; elimi-
nating background chemical noise and
allowing the effects ofeach challenge to sub-
side before introducing the next one would
control apposition; and excluding drugs,
alcohol, nicotine, and caffeine and spacing
introduction ofindividual foods 4 to 7 days
apart would interrupt any addiction.
Individual sensitivity could then be evalu-
ated in the EMU following the postulates in
Figure 7 for etiologicalverification.
For research purposes, challenges must
be performed in a double-blind, placebo-
controlled manner. Patients with chronic
fatigue syndrome, migraine headaches,
seizures, depression, asthma, or unex-
plained illnesses such as Persian Gulfillness
could also be tested for sensitivities in an
EMU using these postulates. Thus, the
EMU could be used to determine whether
particular patients with these diagnoses had
a masked form ofthis illness.
What evidence is there that unmasking
patients in an EMU and conducting chal-
lenges within a 4- to 7-daywindow oftime
is either useful or necessary? Thousands of
credible patients and dozens ofphysicians
have attempted this approach. They report
that patients' symptoms resolve within a
few days after they enter such a facility and
that robust symptoms occur when chal-
lenges are conducted after several days of
avoidance. Other evidence corroborates
these observations: Withdrawal symptoms
of several days' to a week's duration are
known to occur in some persons following
cessation of exposure to nitroglycerine
(dynamite workers' headaches) (27), caf-
feine (18,28), nicotine, and alcohol. Note
that these substances are chemically unre-
lated. In individuals chronically exposed to
xylene (29) or ozone (30), reexposure after
several days' avoidance results in robust
symptoms. Foods may require one to sev-
eral days to navigate the digestive tract
before they are eliminated. Taken together,
these observations suggest that individuals
with sensitivities to multiple incitants
might experience effects that linger as long
as several days following initial avoidance.
Thus, it may be argued that patients
should be removed from their entire back-
ground offood and chemical exposures for
4 to 7 days before challenges, as Randolph
first proposed (14,17).
While it is conceivable that synergistic or
additive chemical combinations maybe nec-
essary to reproduce certain symptoms, this is
alimitation ofany form ofchallenge testing.
Wherever possible within the bounds of
safety and feasibility, chemical combinations
believed to precipitate the most robust and
measurable responses should be explored.
However, 40 years ofclinical observations,
although anecdotal, suggest that single test
substances may suffice for most sensitive
subjects. Confirmation or refutation of
these claims seems a logical first step that
should precede testing of complex mix-
tures. Finally, because isolating patients in
a hospital environment like the EMU may
have unanticipated psychological conse-
quences, early studies in this area should
examine the responses ofcontrol subjects
in the same environment.
Conclusion
Good pathological andphysiological theories
provide "a unified, clear, and entirely intelli-
gible meaning for a whole series ofanatomi-
cal and clinical facts, and for the relevant
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experiences and discoveries of reliable
observers..." (31). Theories and experi-
ments that overlook salient observations or
do not control experimental conditions ade-
quately may lead to erroneous conclusions.
During the late 19th century, researchers
collected sputum from patients with tuber-
culosis but were unsuccessful in culturing
any organism. Some concluded that tuber-
culosis was not an infectious disease. These
early investigators did not know that the
tuberculin bacillus was fastidious and would
grow out only after many weeks on a spe-
cialized culture medium. Correspondingly,
scientists' abilities to observe and under-
stand chemical sensitivity may depend on
optimizing experimental conditions, that is,
appropriate timing ofchallenges and use of
an EMU for unmasking patients. To date,
studies in this area have failed to unmask
patients before challenge. When false posi-
tive and false negative responses occurred,
investigators concluded that chemical sensi-
tivitywas psychogenic in origin (32,33).
In summary, features ofTILT overlap
those of allergy, addiction, and classical
toxicity, yet TILT may be distinct from
each of these. TILT appears to involve a
two-step process (resembling allergic sensi-
tization) in which persons lose specific tol-
erance (resembling addiction) for a wide
range of common substances following a
chemical exposure event (resembling toxic-
ity). Just as the germ theory describes a
class ofdiseases sharing the general mecha-
nism ofinfection, the TILT theory ofdis-
ease posits a class of chemically induced
disorders characterized by loss oftolerance
to chemicals, foods, drugs, and food and
drug combinations. In the same way that
fever is a symptom commonly associated
with infectious diseases, chemical sensitiv-
ity may be a symptom associated with the
TILT family ofdiseases. Although clinical
case definitions have been developed that
describe particular infectious diseases, no
clinical case definition can be applied to
the entire class of infectious diseases. The
same may be true for TILT disorders. The
fact that this phenomenon does not fit
already accepted mechanisms for disease is
often offered as evidence that the condi-
tion does not exist. However, the same
criticism would have applied to the germ
and immune theories ofdisease when they
first were proposed. What is plausible
depends on the biological knowledge of
the time (34).
Looking to the future, carefully con-
ducted epidemiological studies and animal
models likely will play important roles in
characterizing the initiation stage ofTILT
during which tolerance is lost. In the
meantime, rigorous testing of the second
stage of TILT, that is, the triggering of
symptoms by tiny doses of chemicals,
foods, drugs, caffeine, or alcohol, is needed
if progress in this area is to occur.
Adopting a set ofrelevant testable hypothe-
ses for etiological verification will ensure
the credibility ofthose endeavors.
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